VAB has been the standard of care for stereotactic/tomosynthesis and MRI-guided biopsies for many years, but Mammotome VAB is also engineered for optimized outcomes for ultrasound cases.1
1. as compared to 14G spring-fired core needle devices
History
VAB was first brought to market in 1995 when the original Mammotome® system was released to provide an accurate diagnosis, while greatly improving the overall patient experience.